A case of very long-term appearing drug tolerance to intrathecal baclofen

I. Dones, G. Broggi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

A 66-year-old man affected by familial spastic paraplegia since he was 22 developed drug tolerance to intrathecal baclofen after 16 years of treatment. A stable dosage of 850 μg/day, achieved after the first two years, appeared to be progressively inadeguate to relief his spasticity. No other evidence of additional diseases or progression of his neurological disease were recognized. The daily dosage was then increased to 1200 μg/day without any decrease in spasticity or improvement in the patient's motor performance. Thus a slow and progressive decrease of the daily dosage was performer by 10% each 15 days while the patient's clinical condition was monitored. The patient reached a complete withdrawal of the baclofen administration experiencing the same spasticity and motor performance he experienced at the beginning of his therapy with intrathecal baclofen in 1991. The patient was then kept on drug holiday for three months without any variation in his clinical picture. A stabilized daily baclofen dosage of 250 μg was then reached to maintain the same improvement of motor performance that the patient had experienced before the onset of drug-tolerance signs. Some cases of drug tolerance to intrathecal baclofen were previously reported but this is an original case of very long-term onset of this phenomenon.

Original languageEnglish
Pages (from-to)77-78
Number of pages2
JournalJournal of Neurosurgical Sciences
Volume54
Issue number2
Publication statusPublished - Jun 2010

Fingerprint

Drug Tolerance
Baclofen
Holidays
Paraplegia
Disease Progression
Therapeutics
Pharmaceutical Preparations

Keywords

  • Baclofen
  • Drug tolerance
  • Muscle spasticity

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

A case of very long-term appearing drug tolerance to intrathecal baclofen. / Dones, I.; Broggi, G.

In: Journal of Neurosurgical Sciences, Vol. 54, No. 2, 06.2010, p. 77-78.

Research output: Contribution to journalArticle

@article{f9a42fe114b945b1bdd1861b1e98c8b0,
title = "A case of very long-term appearing drug tolerance to intrathecal baclofen",
abstract = "A 66-year-old man affected by familial spastic paraplegia since he was 22 developed drug tolerance to intrathecal baclofen after 16 years of treatment. A stable dosage of 850 μg/day, achieved after the first two years, appeared to be progressively inadeguate to relief his spasticity. No other evidence of additional diseases or progression of his neurological disease were recognized. The daily dosage was then increased to 1200 μg/day without any decrease in spasticity or improvement in the patient's motor performance. Thus a slow and progressive decrease of the daily dosage was performer by 10{\%} each 15 days while the patient's clinical condition was monitored. The patient reached a complete withdrawal of the baclofen administration experiencing the same spasticity and motor performance he experienced at the beginning of his therapy with intrathecal baclofen in 1991. The patient was then kept on drug holiday for three months without any variation in his clinical picture. A stabilized daily baclofen dosage of 250 μg was then reached to maintain the same improvement of motor performance that the patient had experienced before the onset of drug-tolerance signs. Some cases of drug tolerance to intrathecal baclofen were previously reported but this is an original case of very long-term onset of this phenomenon.",
keywords = "Baclofen, Drug tolerance, Muscle spasticity",
author = "I. Dones and G. Broggi",
year = "2010",
month = "6",
language = "English",
volume = "54",
pages = "77--78",
journal = "Journal of Neurosurgical Sciences",
issn = "0026-4881",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "2",

}

TY - JOUR

T1 - A case of very long-term appearing drug tolerance to intrathecal baclofen

AU - Dones, I.

AU - Broggi, G.

PY - 2010/6

Y1 - 2010/6

N2 - A 66-year-old man affected by familial spastic paraplegia since he was 22 developed drug tolerance to intrathecal baclofen after 16 years of treatment. A stable dosage of 850 μg/day, achieved after the first two years, appeared to be progressively inadeguate to relief his spasticity. No other evidence of additional diseases or progression of his neurological disease were recognized. The daily dosage was then increased to 1200 μg/day without any decrease in spasticity or improvement in the patient's motor performance. Thus a slow and progressive decrease of the daily dosage was performer by 10% each 15 days while the patient's clinical condition was monitored. The patient reached a complete withdrawal of the baclofen administration experiencing the same spasticity and motor performance he experienced at the beginning of his therapy with intrathecal baclofen in 1991. The patient was then kept on drug holiday for three months without any variation in his clinical picture. A stabilized daily baclofen dosage of 250 μg was then reached to maintain the same improvement of motor performance that the patient had experienced before the onset of drug-tolerance signs. Some cases of drug tolerance to intrathecal baclofen were previously reported but this is an original case of very long-term onset of this phenomenon.

AB - A 66-year-old man affected by familial spastic paraplegia since he was 22 developed drug tolerance to intrathecal baclofen after 16 years of treatment. A stable dosage of 850 μg/day, achieved after the first two years, appeared to be progressively inadeguate to relief his spasticity. No other evidence of additional diseases or progression of his neurological disease were recognized. The daily dosage was then increased to 1200 μg/day without any decrease in spasticity or improvement in the patient's motor performance. Thus a slow and progressive decrease of the daily dosage was performer by 10% each 15 days while the patient's clinical condition was monitored. The patient reached a complete withdrawal of the baclofen administration experiencing the same spasticity and motor performance he experienced at the beginning of his therapy with intrathecal baclofen in 1991. The patient was then kept on drug holiday for three months without any variation in his clinical picture. A stabilized daily baclofen dosage of 250 μg was then reached to maintain the same improvement of motor performance that the patient had experienced before the onset of drug-tolerance signs. Some cases of drug tolerance to intrathecal baclofen were previously reported but this is an original case of very long-term onset of this phenomenon.

KW - Baclofen

KW - Drug tolerance

KW - Muscle spasticity

UR - http://www.scopus.com/inward/record.url?scp=78649379732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649379732&partnerID=8YFLogxK

M3 - Article

VL - 54

SP - 77

EP - 78

JO - Journal of Neurosurgical Sciences

JF - Journal of Neurosurgical Sciences

SN - 0026-4881

IS - 2

ER -